Literature DB >> 26947932

RUNX1 amplification in AML with myelodysplasia-related changes and ring 21 chromosomes.

S Burillo-Sanz1, M T Vargas2, R M Morales-Camacho2, T Caballero-Velázquez2, J Sánchez3,4, J R García-Lozano1, I Pérez de Soto2, C Prats-Martín2, R Bernal2, J A Pérez-Simón2.   

Abstract

Ring 21 is an unstable structural abnormality of chromosome 21 that can lead to RUNX1 gene amplification. We present a unique case with a carrier patient of a constitutional ring chromosome 21 (partial monosomy and trisomy 21) with dysmorphic features and congenital malformations phenotype, who developed acute myeloid leukaemia with myelodysplasia-related changes and two ring 21 chromosomes with RUNX1 amplification. The patient's constitutional ring 21 chromosome showed alterations in tumour suppressor genes, and oncogenes, but not in RUNX1. RUNX1 gene expression at acute myeloid leukaemia diagnosis, showed no upregulation, so other genes may also be the genetic amplification targets in this patient.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  AML; RUNX1 amplification; r(21)

Mesh:

Substances:

Year:  2016        PMID: 26947932     DOI: 10.1002/hon.2287

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


  3 in total

1.  21q22 amplification detection in three patients with acute myeloid leukemia: cytogenomic profiling and literature review.

Authors:  Emily M Kudalkar; Changlee Pang; Mary M Haag; Daniel A Pollyea; Manali Kamdar; Gang Xu; Meng Su; Billie Carstens; Karen Swisshelm; Liming Bao
Journal:  Mol Cytogenet       Date:  2022-07-07       Impact factor: 1.904

Review 2.  The past, present, and future for constitutional ring chromosomes: A report of the international consortium for human ring chromosomes.

Authors:  Peining Li; Barbara Dupont; Qiping Hu; Marco Crimi; Yiping Shen; Igor Lebedev; Thomas Liehr
Journal:  HGG Adv       Date:  2022-09-10

Review 3.  RUNX family: Oncogenes or tumor suppressors (Review).

Authors:  Beatriz Andrea Otálora-Otálora; Berta Henríquez; Liliana López-Kleine; Adriana Rojas
Journal:  Oncol Rep       Date:  2019-05-06       Impact factor: 3.906

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.